Adage Capital Partners’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,400,000
| Closed | -$36.6M | – | 742 |
|
|
2018
Q4 | $36.6M | Sell |
1,400,000
-100,000
| -7% | -$2.61M | 0.1% | 224 |
|
|
2018
Q3 | $34.4M | Buy |
1,500,000
+100,000
| +7% | +$2.3M | 0.08% | 293 |
|
|
2018
Q2 | $26.7M | Hold |
1,400,000
| – | – | 0.06% | 339 |
|
|
2018
Q1 | $23.6M | Buy |
1,400,000
+1,205,459
| +620% | +$20.3M | 0.05% | 359 |
|
|
2017
Q4 | $2.96M | Buy |
+194,541
| New | +$2.96M | 0.01% | 651 |
|
|
2015
Q4 | – | Sell |
-750,000
| Closed | -$8.46M | – | 742 |
|
|
2015
Q3 | $8.46M | Buy |
750,000
+275,000
| +58% | +$3.1M | 0.02% | 557 |
|
|
2015
Q2 | $6.03M | Buy |
475,000
+125,000
| +36% | +$1.59M | 0.02% | 615 |
|
|
2015
Q1 | $3.26M | Sell |
350,000
-25,000
| -7% | -$233K | 0.01% | 661 |
|
|
2014
Q4 | $5.37M | Buy |
+375,000
| New | +$5.37M | 0.01% | 615 |
|